Endocyte Inc (NASDAQ:ECYT)

7.36
Data as of Aug 29
 +0.3799 / +5.44%
Today’s Change
5.91
Today|||52-Week Range
33.70
-31.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$305.8M

Company Description

Endocyte, Inc. is a biopharmaceutical company, which develops targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.

Contact Information

Endocyte, Inc.
3000 Kent Avenue
West Lafayette Indiana 47906
P:(765) 463-7175
Investor Relations:

Employees

Shareholders

Mutual fund holders29.46%
Individual stakeholders21.98%
Other institutional17.56%

Top Executives

P. Ron EllisPresident, Chief Executive Officer & Director
Michael A. ShermanChief Operating & Financial Officer
Philip S. LowDirector & Chief Science Officer
Christopher P. LeamonVice President-Research & Development
Binh NguyenVice President-Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.